CLOs on the Move

Kaleido Biosciences

www.kaleido.com

 
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.kaleido.com
  • 18 Crosby Drive
    Bedford, MA USA 01730
  • Phone: 617.674.9000

Executives

Name Title Contact Details
Jerald Korn
 General Counsel and Corporate Secretary Profile

Similar Companies

Dixon Information Inc

Dixon Information Inc is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quest Imaging Medical Associates

Quest Imaging Medical Associates is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DiaDexus

Diadexus is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. We pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker`s utility. Our products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014. Our pipeline of advanced cardiac biomarkers includes biomarkers for heart failure, proADM, proET-1 and proANP. Each marker gives distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. Our portfolio of advanced cardiac biomarkers is available to be paired with novel therapeutics in development for indications where cardiovascular risk information would provide valuable insights. This information can be used by pharmaceutical companies in targeting the appropriate patient population and understanding the potential long-term side effects for their therapeutics, potentially avoiding long-term follow up studies.

Applied Genetics Laboratories

Applied Genetics Laboratories is a Melbourne, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A.N.B. Laboratories Co.

A.N.B. Laboratories Co. is a Bangkok, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.